CD4 and leukemia: For example, expression of human MHC class I and II transgenes in NSG mice has facilitated the study of CD8+ and CD4+ T cell responses in graft-versus-leukemia immunity (Ehx et al., 2018) and colitis (Goettel et al., 2016), respectively, in Hu-PBMC-NSG mice.